General Information of the Compound
Compound ID
CP0482194
Compound Name
2-(2-hydroxy-3-piperidin-1-ylpropoxy)anthracene-9,10-dione
    Show/Hide
Structure
Formula
C22H23NO4
Molecular Weight
365.429
Canonical SMILES
OC(COc1ccc2C(=O)c3ccccc3C(=O)c2c1)CN1CCCCC1
    Show/Hide
InChI
InChI=1S/C22H23NO4/c24-15(13-23-10-4-1-5-11-23)14-27-16-8-9-19-20(12-16)22(26)18-7-3-2-6-17(18)21(19)25/h2-3,6-9,12,15,24H,1,4-5,10-11,13-14H2
    Show/Hide
InChIKey
PXWCKUXFCXALLR-UHFFFAOYSA-N
Physicochemical Property
logP
2.6876
Rotatable Bonds
5
Heavy Atom Count
27
Polar Areas
66.84
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 3462291
ChEMBL ID
CHEMBL2070833
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00862, Adenosine receptor A2a
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
Ki = 5011.87 nM
   TI
   LI
   LO
   TS